HLA-DRB1*15:01 and DRB1*15 alleles are associated with low JCV antibody positive rate and index, whereas DRB1*04 is associated with high JCV antibody positive rate in Japanese MS patients, excluding DRB1*15 carriers. Here, HLA-DRB1 is linked to myeloid sarcoma.